Current Knowledge and Future Directions in Psoriasis: The Full Cycle of Psoriasis Care in 2024

Course Overview

Join us for IPC’s Global Webinar Series, Current Knowledge and Future Directions: The Full Cycle of Psoriasis Care in 2024. This series will focus on patient care, emphasizing advancements, innovative treatments, personalized patient management, and the trajectory of future developments in psoriasis. Through four engaging webinars, IPC’s global network of psoriasis experts will discuss cutting-edge insights, innovative models, and actionable strategies for optimizing patient outcomes.

The agendas have been thoughtfully designed to provide practical insights and strategies for integrating new treatments and patient-focused approaches into clinical practice. Participants will benefit from dynamic discussions and interactive Q&A sessions with leading experts in the field.

  • Unravel the concept of value-based health care, exploring its application in dermatology.
  • Look inside the Integrated Practice Unit model, drawing parallels from diverse medical specialties and proposing a tailored approach for psoriasis management.
  • Deliver recommendations for best-value treatment for various psoriasis subtypes, from guttate to palmoplantar.
  • Highlight the pivotal role of doctors and health care practitioners in driving transformative care delivery through task delegation and team-based approaches.

Don’t miss this opportunity to stay at the forefront of psoriasis management and improve patient outcomes in 2024 and beyond.

Agendas

The Full Cycle of Psoriasis Care in 2024: Value or Volume?


WELCOME + INTRODUCTION 

Deepak Balak, MD, PhD, MSc, Netherlands
Ricardo Romiti, MD, PhD, Brazil

Value-Based Healthcare – A Primer
Willem Jan Bos, MD, PhD, Netherlands

Successes of Value-Based Healthcare – An Example from The Netherlands
Paul van der Nat, MD, PhD, Netherlands

What Exists in Dermatology and Psoriasis
Deepak Balak, MD, PhD, MSc, Netherlands

Q&A + CLOSING COMMENTS
Deepak Balak, MD, PhD, MSc, Netherlands
Ricardo Romiti, MD, PhD, Brazil

The Integrated Practice Unit Model


WELCOME + INTRODUCTION

Jo Lambert, MD, PhD, Belgium

Advantages of the Integrated Practice Unit
Marcia Makdisse, MD, MSc, PhD, MBA, MSHCT, Brazil

Integrated Practice Units – An Example from Rheumatology
Fiona Koster, Netherlands

Proposing a Model for Psoriasis
Elfie Deprez, Belgium

Q&A + CLOSING COMMENTS
Jo Lambert, MD, PhD, Belgium

Can We Deliver the Best Value Yet?


WELCOME + INTRODUCTION
Curdin Conrad, MD, Switzerland

Treatment Options for Guttate Psoriasis
Curdin Conrad, MD, Switzerland

Treatment Options for Palmoplantar and Nail Psoriasis
Tiago Torres, MD, PhD, Portugal

Treatment Options for Psoriasis in High Impact Areas
Cristina Echeverría, MD, Argentina

Q&A + CLOSING COMMENTS
Curdin Conrad, MD, Switzerland

The Role Doctors and Other Healthcare Practitioners Can Play


WELCOME + INTRODUCTION

Chris Griffiths, OBE, MD, FMedSci, United Kingdom

Task Delegation in the Clinic: Workforce Redesign
Ann Van Hecke, PhD, Belgium

The Team Approach: An Example from Manchester
Chris Griffiths, OBE, MD, FMedSci, United Kingdom

The Team Approach: Can Costs Drive Reorganization?
Joke Borzée, MBE, Belgium

Q&A + CLOSING  COMMENTS
Elfie Deprez, PhD, Belgium

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026